Citations

Mayo Clinic

Showing 10 of 108572 citations.

Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement
Spuls, Phyllis I. , Gerbens, Louise A. A. , Simpson, Eric L. , Apfelbacher, Christian , Thomas, Kim S , Prinsen, C.A.C. , Kobyletzki, L.B. von , Williams, Hywel C , Schmitt, Jochen , collaborators, the HOME initiative, Spuls, P I , Gerbens, L A A , Apfelbacher, C J , Thomas, K S , Chalmers, Joanne R , Singh, Jasvinder A. , collaborators, the HOME initiative

British Journal of Dermatology | November 18, 2016 | Volume: 176 | Issue: 4 | Pages: 979-984

10.1111/bjd.15179 | PMID 27858989 Get It

Novel approaches to early detection of endometrial cancer
Bagaria, Madhu, Shields, Emily, Bakkum‐Gamez, Jamie N.

Current Opinion in Obstetrics & Gynecology | November 18, 2016 | Volume: 29 | Issue: 1 | Pages: 40-46

10.1097/gco.0000000000000332 | PMID 27861202 Get It

Purpose of reviewDetection of endometrial cancer at an early stage leads to better oncologic outcomes. To date, a screening test for endometrial cancer does not exist.Recent findingsEvolving knowledge of molecular changes involved in endometrial cancer carcinogenesis paired with sensitive and high-throughput technological advancements are a promising combination that can be leveraged to detect tumor DNA and proteins. These molecular biomarkers can be identified in biospecimens collected via minimally invasive and noninvasive approaches. Exploiting lower genital tract secretions as a biospecimen also allows for patient self-sampling.SummarySuccessful development of a screening test for endometrial cancer using self-collected lower genital tract biospecimens has the potential to increase accessibility to care and improve patient compliance.
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors
Jouni, Hayan, Aubry, Mary C., Lacy, Martha Q. , Kumar, Shaji , Frye, Robert L. , Herrmann, Joerg , Rajkumar, S. Vincent

American Journal of Hematology | November 17, 2016 | Volume: 92 | Issue: 2 | Pages: 220-221

10.1002/ajh.24608 | PMID 27859518 Get It

Prevalence and Contents of Advance Directives of Patients with ESRD Receiving Dialysis
Feely, Molly A., Hildebrandt, Daniel, Varayil, Jithinraj Edakkanambeth , Mueller, Paul S. , Edakkanambeth Varayil, Jithinraj, Edakkanambeth Varayil, Jithinraj

Clinical Journal of the American Society of Nephrology | November 17, 2016 | Volume: 11 | Issue: 12 | Pages: 2204-2209

10.2215/cjn.12131115 | PMID 27856490 Get It

Background and objectives ESRD requiring dialysis is associated with increased morbidity and mortality rates, including increased rates of cognitive impairment, compared with the general population. About one quarter of patients receiving dialysis choose to discontinue dialysis at the end of life. Advance directives are intended to give providers and surrogates instruction on managing medical decision making, including end of life situations. The prevalence of advance directives is low among patients receiving dialysis. Little is known about the contents of advance directives among these patients with advance directives. Design, setting, participants, & measurements We retrospectively reviewed the medical records of all patients receiving maintenance in–center hemodialysis at a tertiary academic medical center between January 1, 2007 and January 1, 2012. We collected demographic data, the prevalence of advance directives, and a content analysis of these advance directives. We specifically examined the advance directives for instructions on management of interventions at end of life, including dialysis. Results Among 808 patients (mean age of 68.6 years old; men =61.2%), 49% had advance directives, of which only 10.6% mentioned dialysis and only 3% specifically addressed dialysis management at end of life. Patients who had advance directives were more likely to be older (74.5 versus 65.4 years old; P <0.001) and have died during the study period (64.4% versus 46.6%; P <0.001) than patients who did not have advance directives. Notably, for patients receiving dialysis who had advance directives, more of the advance directives addressed cardiopulmonary resuscitation (44.2%), mechanical ventilation (37.1%), artificial nutrition and hydration (34.3%), and pain management (43.4%) than dialysis (10.6%). Conclusions Although one-half of the patients receiving dialysis in our study had advance directives, end of life management of dialysis was rarely addressed. Future research should focus on improving discernment and documentation of end of life values, goals, and preferences, such as dialysis–specific advance directives, among these patients.
Current understanding and approach to well differentiated lung neuroendocrine tumors: an update on classification and management
Hilal, Talal , Hilal, Talal

Therapeutic Advances in Medical Oncology | November 17, 2016 | Volume: 9 | Issue: 3 | Pages: 189-199

10.1177/1758834016678149 | PMID 28344664 Get It

Neuroendocrine tumors (NETs) are rare neoplasms that can arise from any tissue. They are classified based on embryonic gut derivative (i.e. foregut, midgut and hindgut) with midgut tumors being the most common (e.g. gastrointestinal NET). The second most common category of NETs is that which arises from the lung. In fact, 25% of primary lung cancers are NETs, including small cell lung cancer (SCLC), which comprises 20% of all lung cancers. The remaining 5% are large cell neuroendocrine cancer (LCNEC, 3%), typical carcinoids (TCs, 1.8%), and atypical carcinoids (ACs, 0.2%). The less common TCs/ACs are well differentiated lung NETs. Their incidence has been increasing in more recent years and although these tumors are slow growing, advanced disease is associated with poor survival. There have been advances in classification of lung NETs that have allowed for more appropriate management upfront. They are cured by surgical resection when disease is limited. However, advanced and metastatic disease requires medical therapy that is ever changing and expanding. In this review, the aim is to summarize the current understanding and classification of well differentiated lung NETs (i.e. TCs and ACs), and focus on recent updates in medical management of advanced disease, along with a brief discussion on potential future discoveries.
Neurovascular control of blood pressure is influenced by aging, sex, and sex hormones
Baker, Sarah E. , Limberg, Jacqueline K. , Ranadive, Sushant M. , Joyner, Michael J. , Ranadive, Sushant M. , Joyner, Michael J , Baker, Sarah E , Ranadive, Sushant

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | November 17, 2016 | Volume: 311 | Issue: 6 | Pages: R1271-R1275

10.1152/ajpregu.00288.2016 | PMID 27856414 Get It

In this review, we highlight that the relationship between muscle sympathetic nerve activity (MSNA) and mean arterial pressure is complex, differs by sex, and changes with age. In young men there is an inverse relationship between MSNA and cardiac output where high MSNA is compensated for by low cardiac output. This inverse relationship is not seen in older men. In young women sympathetic vasoconstriction is offset by β-adrenoreceptor mediated vasodilation, limiting the ability of young women to maintain blood pressure in response to orthostatic stress. However, β-mediated dilation in women is attenuated with age, leading to unopposed α-adrenergic vasoconstriction and a rise in the direct transduction of MSNA into increases in blood pressure. We propose that these changes with age and menopausal status are major contributing factors in the increased prevalence of hypertension in older women. In addition to aging, we highlight that changes in sex hormones in young women (across the menstrual cycle, with oral contraceptive use, or with pregnancy) influence MSNA and the transduction of MSNA into increases in blood pressure. It is likely that the β-adrenergic receptors and/or changes in baroreflex sensitivity play a large role in these sex differences and changes with alterations in sex hormones.
Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry
Kourelis, Taxiarchis , Dasari, Surendra , Theis, Jason D. , Ramı́rez-Alvarado, Marina , Kurtin, Paul J. , Zeldenrust, Steven R., Zenka, Roman M. , Gertz, Morie A. , Doǧan, Ahmet , Dispenzieri, Angela , Ramirez-Alvarado, Marina

Blood | November 17, 2016 | Volume: 129 | Issue: 3 | Pages: 299-306

10.1182/blood-2016-10-743997 | PMID 27856462 Get It

Key Points Mass spectrometry is a high-throughput, low-resource technique that can identify immunoglobulin variable region gene from tissue specimens. IGVL gene usage is restricted and different between systemic and localized AL and only partially explains organ tropism in this disease.
Drospirenone Litigation: Does the Punishment Fit the Crime?
Batur, Pelin , Casey, Petra M.

Journal of Women's Health | November 17, 2016 | Volume: 26 | Issue: 2 | Pages: 99-102

10.1089/jwh.2016.6092 | PMID 27854556 Get It

The Capabilities and Limitations of Clinical Magnetic Resonance Imaging for Detecting Kidney Stones: A Retrospective Study
Ibrahim, El-Sayed H. , Cernigliaro, Joseph G. , Bridges, Mellena D., Pooley, Robert A. , Haley, William E. , Haley, William E

International Journal of Biomedical Imaging | November 17, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-6

10.1155/2016/4935656 | PMID 27980535 Get It

The purpose of this work was to investigate the performance of currently available magnetic resonance imaging (MRI) for detecting kidney stones, compared to computed tomography (CT) results, and to determine the characteristics of successfully detected stones. Patients who had undergone both abdominal/pelvic CT and MRI exams within 30 days were studied. The images were reviewed by two expert radiologists blinded to the patients’ respective radiological diagnoses. The study consisted of four steps: (1) reviewing the MRI images and determining whether any kidney stone(s) are identified; (2) reviewing the corresponding CT images and confirming whether kidney stones are identified; (3) reviewing the MRI images a second time, armed with the information from the corresponding CT, noting whether any kidney stones are positively identified that were previously missed; (4) for all stones MRI-confirmed on previous steps, the radiologist experts being asked to answer whether in retrospect, with knowledge of size and location on corresponding CT, these stones would be affirmed as confidently identified on MRI or not. In this best-case scenario involving knowledge of stones and their locations on concurrent CT, radiologist experts detected 19% of kidney stones on MRI, with stone size being a major factor for stone identification.
Pulmonary Hypertension and Palliative Care: What, When, Where, and Why?
Fenstad, Eric R. , Wordingham, Sara E., Swetz, Keith M.

Advances in Pulmonary Hypertension | November 17, 2016 | Volume: 15 | Issue: 1 | Pages: 26-31

10.21693/1933-088x.15.1.26 Get It

Summary: Pulmonary hypertension (PH) can be associated with a high level of symptom burden from the disease as well as its treatment. Involvement of palliative care (PC) services may help facilitate discussion regarding goals of care, prognostic planning, and treatment options focused on improving quality of life (QOL). Background: PC is active total care of a patient whose disease is not fully responsive to curative therapies, with symptom control as the top priority. After a life-limiting diagnosis is made, health care teams and patients determine prognosis, whether cure is attainable or reasonable, what treatment options are available, risks and benefits of associated treatments, and how treatment or nontreatment will impact QOL and survival. QOL is often the focus of palliative interventions, with the goal to minimize symptoms and empower patients with accurate information to help affirm life and meet objectives of care. Implications for clinicians: PC can begin at the onset of symptoms in a disease that cannot be cured. Early PC may help facilitate discussion regarding goals of care when patient expectations are discordant with prognosis. While PC is a responsibility of all clinicians, subspecialist assistance can be helpful when a clinical decline occurs, in the setting of uncertainty, when patients are removed from the transplant list, or when long-term QOL issues are present. Conclusion: Communication with patients who have PH can be delicate and requires an understanding of the disease's process, trajectory, and prognosis. PC teams possess communication skills that may benefit patients and providers with QOL optimization, delivery of difficult news, advanced care planning, and shared decision-making.